In a phase 2 trial, firsekibart — an IL-1 beta antibody — outperforms colchicine in preventing acute gout flares over 12 ...

If you’ve ever been going about your day only to get hit with excruciating joint pain, it could be gout. While this type of arthritis is often associated with sharp, sudden pain in the big toe, gout ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy ...

Have you ever kicked off your shoes after a long day and realized your big toe was throbbing? If so, you aren’t alone. Big toe joint pain is a common, but crippling, foot problem. Thankfully, various ...

Full results from the so-called MIRROR trial have now been published and suggest the FDA made the right decision this summer to approve methotrexate as an add-on to pegloticase (Krystexxa) for ...

Scientists identify a new molecular model and potential therapeutic target for gout, the most common form of inflammatory arthritis. Many Americans think of gout as a disease from a bygone era, akin ...

TOKYO, Jul 14, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it has launched "URECE" (brand name in China: "Youlesi", generic name: ...

Gout is a growing threat to the world population. Moreover, the prevalence of comorbidities is higher in gout patients. Study: Urate-Lowering Therapy Use among US Adults with Gout and the Relationship ...

Management of a patient allergic to allopurinol can be considered a therapeutic challenge. This article highlights the diversity of medications that can be used to manage hyperuricemia during this ...